Corrigendum

This article refers to:

Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults

Article title: Safety, tolerability and immunogenicity of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young adults

Authors: Pierre Van Damme, Gianmaria Minervini, Charles L. Liss, Barbara McCarson, Timo Vesikari, John W. Boslego, Prakash K. Bhuyan

Journal: Human Vaccines & Immunotherapeutics

Bibliometrics: Volume 5, issue 2, pages 92–97

DOI: 10.4161/hv.5.2.6587

The clinicaltrials.gov registration number (NCT number) was not published in the article. The NCT number is NCT00489099.

The authors apologize for any inconvenience caused.